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In 2010, UCLPartners, a partnership of health care providers and universities in North Central London, began a 
collaboration with local commissioners that aimed to think about cancer care and diagnosis diff
that a good patient experience can only be delivered by putting patients
from symptoms to recovery, we brought
for patients, outside institutional barriers
focused on understanding what mattered most to patients and organising how it worked and how it measured success 
around this. Co-designed by conversations and with
London Cancer’s ten things that matter most to patients are embedded throughout the continuing work of this 
organisation. In this article our work to develop these
patient centred integrated cancer system for a population of 3.5 million people in London and Essex.
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The vision and need for patient centred care in the 
National Health Service has been stated consistently, but 
with increasing vigour, over the last 3 years. The Francis
Keogh2 and Berwick3 Reports of 2013 all highlight the 
challenges posed by a health service that does not respond 
to the concerns of patients and their families and carers. 
While there are many varied definitions of patient or 
person centred care, we will use the National Voi
simple definition of “organised around the needs of 
individuals”4.   
 
Turning patient centred care from rhetoric to reality is one 
of the greatest cultural challenges for health and social care 
organisations. This article outlines how a London
integrated cancer system, London Cancer (Figure 1)
collaboration of patients, hospitals, charities and local 
General Practitioners (GPs) working along the patient 
pathway, assessed what mattered most to cancer patients 
-131 
 




, katherine.joel1@nhs.net  
  
, kathy.pritchard-jones@uclpartners.com  
erently. 
 first and working together along their journey 
 clinical leaders together with patients to think about how to
. From the very beginning this new network, an integrated cancer system, 
 contributions from over 1,000 clinicians and over 200
 ten topics is described alongside how we used this to create a truly 
experience, patient engagement, patient involvement, practice, 





within its region. It describes the 
priorities, championed by local clinical leaders who role
modeled these values, and how it has used this ‘what 
matters most’ framework to develop pathways of care and 
pathway measures that reflect that they treat people, not 
simply diseases. 
 
In 2010, 67,713 patients responded to England’s National 
Cancer Patient Experience survey, which provided insights 
into the care experienced by cancer patients across 
England who were treated as day cases or inpatients 
during the first three months of 2010. Building on a 
previous survey undertaken in 2000 involving over 65,000 
cancer patients and a smaller survey undertaken in 2004 
involving 4,300 patients, the 2010 survey revealed that 
London patients were significantly more critical of cancer 
services in regards to: 








co-production of these 
-
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• getting understandable answers to important 
questions from ward nurses; 
• contacting their Clinical Nurse Specialist; 
• the general organisation of NHS services, especially 
those “reaching” into the community and primary 
care.5  
 
Many of the areas where London performed poorly related 
to fragmentation as patients moved between organisations, 
and not having all their questions answered. By engaging 
with existing and new patient audiences and local clinical 
teams, London Cancer set about defining priorities for local 





Background to London’s First Integrated Cancer 
System 
 
In 2010, UCLPartners, at the time a fairly small 
partnership of health care providers and universities in 
North Central London, was asked, in partnership with 
local commissioners, to host and develop a cancer services 
provider network. This was envisaged to be fundamentally 
different from the previous English Cancer Networks’ way 
of working, with a primary focus on patients, rather than 
organisational performance, using their voice, through co-
design and development, to change services for the better 
with clinicians and staff. The Cancer Networks worked 
through clinically led ‘Network Site Specific Groups’ with 
a separate patient advisory group, known locally as the 
Cancer Partnership Group, working alongside these 
groups. The new integrated cancer system proposed 
having patients embedded in co-design and co-production 
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throughout its work, and as ongoing partners. Initially the 
focus was a population of 1.5 million people in North 
Central London but this grew to 3.5 million with the 
inclusion of North East London (since April 2013 
UCLPartners has expanded to include mid and South 
Essex, West Hertfordshire and South Bedfordshire, a 
population of over 6 million people).  
 
Officially established in 2012 in partnership with 
commissioners of cancer care, London Cancer is now the 
integrated cancer system for North Central and North 
East London and the west of Essex in England. London 
Cancer is embedded within UCLPartners, an Academic 
Health Science Network (AHSN). UCLPartners’ overall 
purpose is to translate cutting-edge research and 
innovation into measureable health and wealth gains for 
patients and populations by enabling strategic partnership 
working between hospitals, universities, primary and 
community care. For cancer patients, this means we aim to 
accelerate improvements in all aspects of cancer patients’ 
care – from novel and quicker diagnostic pathways 
through reducing variation in both the quality of routine 
care, in access to ‘state of the art’ therapies and innovation, 
to streamlining research delivery so that more patients are 
offered access to clinical trials.  
 
When six specialist providers and three local hospitals 
across North Central London came together in 2010 to 
develop the new integrated cancer system, there were 
several clinical indicators or proxies routinely in use to 
measure cancer outcomes (one year survival, five year 
survival, disease-free progression) but these were generally 
at a population level and not understood well by patients. 
For specific cancers there were no more relevant measures 
or parameters for improvement focused on what patients 
felt was most important for them. The lack of patient-
defined outcomes, particularly around areas of patient 
experience, was a major concern to this area of London, 
where providers received much of England’s poorest 
feedback through the now annual National Cancer Patient 
Experience Survey. It was crucial that the new system 
develop better insight into how it might influence 




Inherent to the change in focus on patient outcomes and 
experience was the emergence of a new type of clinical 
leadership, one driven by values and a desire for 
improvement, rather than process measures or 
institutional dominance. The conversion of Network Site 
Specific Groups, commonly known as Tumour Boards, to 
new Pathway Boards, reflecting through their membership 
all care settings (e.g. primary care, psychological support, 
rehabilitation) and with skilled patient advocates, flowed 
from the new direction of the integrated cancer system. 
Pathway Boards brought patients, primary care, carers and 
allied health professionals to the table alongside surgeons, 
physicians, oncologists and other members of the 
multidisciplinary team. 11 Pathway Boards were set up 
with this diverse membership, alongside 5 Expert 
Reference Groups that provide knowledge and expertise 
of specialist staff working in the areas of chemotherapy, 
radiotherapy, nursing, psychosocial support and acute 
oncology. Many of the Expert Reference Group members 
also sit on a pathway board to bring their discipline-
specific expertise to the tumour-specific discussions. Each 
Pathway Board or Expert Reference Group includes at 
least one patient or carer representative and meetings are 
considered not quorate without one. 
 
Building on the work already started in the system to 
understand the experience of brain patients6, an initial task 
for these new Pathway Boards was to think differently 
about: ‘what does great care look like?’ and if we were to 
achieve it, ‘how the system could know care was great? – 
what would have changed?’  Pathway Boards were 
encouraged to think about what outcomes mattered and 
how they might be measured, what might need to change 
about the areas of activity and responsibility and 
membership to develop a whole-pathway perspective, and 
what kind of leadership would be necessary to ensure a full 
pathway perspective. In November 2010, following 
discussions with their membership, Pathway Board and 
Expert Reference Group Chairs submitted their collective 
responses to the following questions via a tool that asked 
them to outline stages of the pathway and articulate what 
great care would look like in this stage and how we might 
know care was great: 
1. Which 3-5 outcome measures would the Pathway 
Board aim to measure for the whole pathway? 
2. What might need to change about the Pathway Board 
remit [areas of activity and responsibility] & members 
when considering the whole pathways and its 
outcomes? 
3. What might need to be different about the leadership 
of Pathway Boards when overseeing the whole 
pathway? 
4. What might Pathway Boards need to do to improve 
education, benchmarking and dissemination across 
the system (and more widely)? 
 
As may be expected when such an exercise involves such a 
large and diverse group, thinking about care through the 
eyes of patients was variably received by the various 
professional groups.  
 
The team from UCLPartners was supported in the task of 
finding out what mattered most to patients by the North 
Central London and West Essex Cancer Partnership 
Group and the North East London Cancer Partnership 
Group, the service user advisory groups to the previous 
cancer networks. These groups brought together cancer 
patients, carers and healthcare professionals from across 
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the sector interested in improving local cancer services and 
the patient experience.  With over 40 patients and carers 
engaged and involved at any time, it also had involvement 
of local and national charities, including Macmillan Cancer 
Support.  
 
At a meeting in November 2010, the group were asked to 
think about ‘what does great care look like?’ and ‘how 
would you know?’ The Chair (a patient representative) had 
found work that they had previously done for the previous 
network looking at what measures patients and other users 
might care about for hospitals but others at their meeting 
had not yet had a chance to consider the questions. The 
group felt that they would like to revisit this for the whole 
pathway for patients and carers, and look at it in greater 
depth. Using the same tool as the Pathway Boards and 
Expert Reference Groups, with the questions detailed 
above, they focused on what a set of measures of 
achievement and progress, different to those traditional 
population and process measures inherited, might look 
like. The group provided a report to the Pathway Board 
Chairs in January 2011. Staff collated all the responses to 
this exercise and identified themes. A system of grouping 
the items via a thematic approach was agreed with the 
Cancer Partnership Groups, who also reviewed the final 
summary.  
 
Results - What Matters Most? 
 
The following summarises what our communities of 
professionals, patients and carers felt were the aspects of 
the cancer journey that most impacted on their outcome 
and experience. These are not in priority order, as this was 
not assessed, but are listed in what the Cancer Partnership 
Group of patients and carers felt to be the order that 
patients experienced care in their journey through our 
system. While many of these overlap in detail, we have 
presented these as ten distinct areas that matter most to 
London Cancer patients, alongside the context in which the 
discussions evolved. 
 
1. Early Diagnosis 
All involved felt earlier diagnosis of cancer was crucial. In 
North Central London and West Essex 22% of patients 
are diagnosed with cancer only when they arrive at hospital 
for emergency treatment. In North East London, the 
figure is higher at 28%.7 
 
Patients and carers emphasised the importance of public 
information and guidance on healthy living and ways of 
minimising cancer risk and symptoms of common cancers 
and cancer screening programmes.  They encouraged 
further guidance for GPs and suggested more rapid access 
to diagnostic services and associated outpatient 
consultation. Providing education for GPs, community 
care providers, and others such as emergency room staff 
was one suggestion as to how to improve early diagnosis 
by raising awareness of suspicious symptoms to medical 
professionals. It was also apparent from the feedback 
received that raising and sustaining public awareness of 
both prevention, including public health interventions and 
campaigns for issues such as smoking cessation, and for 
cancer screening programmes, was essential. These themes 
were entirely consistent across respondees and led to 
earlier detection and diagnosis becoming one of the most 




Many of the suggestions relating to improving patient 
experience focused on patient choice as a key aspect of 
patient centred care. Patients should have a choice, and the 
ability to make an informed decision, as to what treatment 
to receive and where to receive it. Ensuring the equality of 
access to services for patients, particularly with regards to 
referrals to regional, national and international centres, 
where appropriate, is necessary to offer maximum patient 
choice and the best clinical outcomes. Some of the 
responses overlapped between choice and communication, 
detailing the need to better inform and communicate 
where and when choices might be made. 
 
Research is a crucial element in the effort to improve 
patient care from early diagnosis to choice and 
communication. Providing all patients with the 
opportunity to take part in clinical trials was an aim for 
staff and patients, every patient can make a contribution 
and should be given the opportunity to be considered for 
innovative diagnoses and treatments. The suitability of 
individual patients to participate in clinical trials should be 
discussed at multi-disciplinary team meetings, and patients 
offered trials even if they are open at different sites across 
the system. Enrolment statistics should be reported and 
shared regularly to drive improvement, and the barriers to 
participation understood and addressed. These objectives 




Communication dominated the response from the Cancer 
Partnership Group, with focuses on a number of themes 
within this – breaking bad news; open discussion and 
shared decision-making around treatment options; keeping 
GPs informed throughout treatment; clear communication 
around treatment outcomes; and choice of when, and 
how, to receive information. The importance of bad news 
being delivered sensitively was stressed.  
 
High quality, tailored information should be available to 
both patients and staff. This is essential to ensuring 
patients are able to make informed choices regarding 
treatment decisions, and that they feel supported 
throughout their cancer pathway. Patients felt they should 
decide what level of information is appropriate to them at 
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each stage of their pathway, but should be provided with a 
summary information pack detailing the contact details of 
their key worker, often an advanced practice registered 
nurse, when they first receive their diagnosis. London Cancer 
has focused on improving communication between 
patients and clinicians through a number of projects, 
including delivery of communications training with trained 
counsellors and clinical psychologists, use of the Holistic 
Needs Assessment (detailed below) and working with 
partners to improve written information provision. 
 
4. Travel and Parking 
Patient representatives and key workers also felt patients 
should be provided with information on travel and parking 
options, and the associated cost, prior to their 
appointment. There are several transport alternatives – 
driving; public transport; and patient transport provided 
by hospitals – for attending treatment and appointments in 
London but all have inherent flaws or problems for 
patients. London Cancer has been working with Macmillan 
Cancer Support and the other integrated cancer system in 
London to plan an assessment of the various options 
available to patients and then work with stakeholders, 
including Transport for London and the Mayor’s Office, 
on how to improve. 
 
5. Ethos – patients treated as individuals 
Patients should receive holistic, empathetic, responsive 
and individualised support throughout their pathway. 
Patients and carers felt that clinicians needed to consider 
the implications of treatment options in terms of resultant 
quality of life and possible long term effects of treatment, 
as well more immediate issues of mortality and 
complications. It was felt that patient satisfaction and 
experience scores should serve as a measure of success for 
cancer services. London Cancer partners responded to this 
by committing to work together in a community of 
practice on those areas that could have most impact on 
improving patients’ experience of services, using patient 
satisfaction and experience scores to demonstrate 
improvement. 
 
6. Holistic Assessment of Needs 
Patients felt they should specifically have access to 
complementary therapies and treatments, rehabilitation 
services, and if applicable, to palliative care at the earliest 
possible opportunity. Patients and clinicians felt there 
needed to be a more systematic way to assess the holistic 
needs of each individual patient. Funding from Macmillan 
Cancer Support provided assistance in the integration and 
rapid role out of defined models of assessment and 
support for individuals living with, and beyond, cancer. 
Specific areas of focus have included provision of care 
plans, and the availability of information directly related to 




Support for patients, through formal and informal 
mechanisms, was very important. Patients want to always 
have the option of being accompanied by partner/friend at 
outpatient appointments.  Patients felt having a keyworker 
or clinical nurse specialist from the first appointment made 
a difference to how supported they felt, and suggested 
excellent care included information on support groups, 
counseling services, benefits entitlement, and returning to 
work. To better meet the needs of patients and carers, 
London Cancer has facilitated collaboration between partner 
hospital trusts and the non-profit and voluntary sector, 




Carers should be welcomed, and supported throughout 
the cancer pathway, involved as early as possible in the 
patient journey, and factored into treatment decisions. 
Carers should be encouraged to be fully involved 
throughout the patient pathway. This should be seen as of 
benefit to both the patient and their clinical team. Support 
for carers and families was considered crucial throughout 
the patient journey but particularly around coping with 
advanced cancer and related to end of life care, so that 
there is less anxiety about supporting the patient at home. 
At a system-level, London Cancer has focused on 
encouraging the carer perspective in pathway development 
through a greater number of carer representatives. 
 
9. Discharge 
Patients and carers stressed the importance of a seamless 
and holistic care pathway, which starts and end with a 
General Practitioner, who should help facilitate patient 
discharge following an inpatient stay. GPs should provide 
information and advice to patients, and remain a central 
point of contact across the entire cancer pathway. Patients 
wanted to be given details of the keyworker who would be 
their first point of contact while at home recovering 
following treatment, and clear advice on what symptoms 
might necessitate further action. Appropriate pain relief 
needs to be provided at discharge, with the GP sent 
information on treatment, outcome, and ongoing 
medication and therapy needs.  
 
10. Seamless (Integrated) Care 
There was a strong consensus amongst patients and all 
clinical pathway directors that cancer care should be 
seamless, with patients managed closely during the whole 
pathway through a multi-disciplinary team approach. 
Creating a system whereby patients can follow an 
integrated care pathway between various organisations and 
services across the London Cancer locality was the main 
priority for patients. This extends, but is not limited to, 
creating and sustaining a positive dialogue and relationship 
with: primary and community care, diagnostics, specialist 
medical and surgical services, chemotherapy services, 
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radiotherapy services, pharmacy, psychological support, 
Allied Health Professional services including dietetics and 
physiotherapy, ‘late effects’ services, and palliative care.  
 
Reducing delays within this system was another important 
point raised. Collaborative working and communication 
between the acute providers of cancer care was identified 
as the first step to ensuring this occurs. The ability for 
perceived delays and “gaps” in pathways to lead to anxiety 
and increased distress was noted by many.  Reducing 
variation and bringing providers together across the 
healthcare system, and along the cancer pathway, were 
organising principles for clinicians joining up within the 
London Cancer Pathway Boards to redesign pathways and 




Taking the learning from what our patients had told us, 
aligned with clinicians’ views, the partners within the 
London Cancer system together identified key themes for 
initial focused activity that would align with improving the 
most important aspects of the cancer care journey for local 
people. These key themes have focused on improvements 
in early diagnosis, integration of the care pathway, and 
improving holistic assessment of needs, all underpinned by 
strong partnership and leadership.  
 
Assessing what matters to patients and those caring for 
them, ensuring that there is a shared goal that unites the 
interests and activities of all involved in care, to achieve 
value is fundamental to UCLPartners’ programmatic 
approach, as exemplified in London Cancer. In order to 
ensure pathways were focused on what mattered most, a 
small set of key metrics were identified with the Cancer 
Partnership Groups for each London Cancer Pathway Board 
to monitor their progress in implementing integrated 
cancer care. We have followed Porter’s ethos of: 
“Achieving high value for patients must become the 
overarching goal of health care delivery, with value defined 
as the health outcomes achieved per dollar spent.”8 
 
Value-based metrics were selected only if they were 
clinically useful, in line with the current work plan and 
improvement effort; were accessible on a recurrent basis 
and requiring minimal manual effort; made better use of 
existing data for understanding the entire patient pathway; 
and aligned with London Cancer’s objectives in improving 
survival, patient experience, and access to innovation and 
clinical trials.  
 
Pathway metrics are reported at a system level, reflecting 
the care for our local population, against measures that are 
important to them and will allow visibility of success. 
Current pathway metric development is constrained by the 
availability of meaningful data but local solutions including 
in-house questionnaires and surveys as well as peer 
interviewing have seen a useful focus on attempting to 
measure and track these key items. The profile of those 
things that matter most has been raised within 
organisations across the partnership and underpinned by 
local effort. Alongside this Pathway Boards were 
encouraged to develop annual objectives that could each 
be tangibly related to the ten things, which mattered most 
to patients. 
 




London Cancer led an innovative evaluation in collaboration 
with emergency departments across all nine acute NHS 
hospital trusts and local GP practices in the London Cancer 
region, to understand the reasons why patients are 
diagnosed with cancer in this way.9 This has led to new 
and more responsive measures of emergency presentation 
that will help track this trend in real time. 
 
London Cancer is working collaboratively to shorten the 
patient pathway to diagnosis. Doctor Ed Seward at Barts 
Health NHS Trust (Consultant Gastroenterologist) has 
developed a new service at Whipps Cross Hospital that 
opens up the referral pathway for patients with lower 
gastrointestinal symptoms beyond the strict criteria for 
urgent referral of suspected colorectal cancer.  GPs and 
patients receive a definitive diagnosis more efficiently 
through a ‘straight to test’ model whereby a trained 
specialist nurse assesses patients by telephone.  This 
enables most patients to go directly to the appropriate 
endoscopic investigation, according to symptoms and age, 
rather than attending clinic first. Clear benefits from the 
first 125 patients include faster diagnosis, a reduction in 
missed appointments (3% versus 7% on average), 
unnecessary clinic visits for the trust and cost savings 
across the whole pathway, which could be redeployed for 
capacity, communication with primary care or educational 
activity to aid further earlier diagnosis.10  
 
Integrated and Optimised Care Pathway 
Evidence shows that dedicated specialist centres, treating a 
high volume of patients, staffed by expert teams and 
equipped with the latest technology and research capability 
save lives and reduce complications.11 Clinicians across 
London Cancer have been working closely with partners to 
ensure that we can achieve the best possible outcomes for 
every patient requiring a complex procedure for five rarer 
groups of cancers. Building on commissioners 
recommendations in 2010, clinicians came together to 
develop proposals to consolidate some specialist cancer 
services into a partnership of world-class specialist centres 
in a new connected system of care - including the best 
diagnosis, treatment and recovery care at local hospitals, 
primary and community care services - to provide 
consistently excellent services. Clinicians believe the 
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proposals would allow more rapid improvements in care, 
ensure every patient has access to the full range of 
treatment options and research opportunities and provide 
a consistent level of care no matter where a patient lives or 
first receives care. Now agreed by NHS England and local 
clinical commissioners, the changes, along with 
improvements across the whole care pathway, will save 
over 200 lives a year and significantly improve the safety 
and outcomes of surgery in many others.12  
 
Clinical Trials and Research 
Research studies and clinical trials allow patients to access 
the latest interventions not yet available as part of standard 
care, and help build the evidence base for changes in 
clinical practice that will improve outcomes for all patients. 
Our aim across London Cancer is for researchers at the 
cutting edge of discoveries to work with patients so that 
we can change lives, at a faster pace and at scale13. By 
working together as a coordinated network and linking up 
our clinical practice with leading medical research and 
innovation, we have a remarkable opportunity to give 
patients improved access to clinical trials. We are working 
closely with the newly formed NIHR Clinical Research 
Network: North Thames to improve information for staff 
and patients and access to a full portfolio of studies for 
our population. 14 
 
Improving Holistic Assessment of Needs and Ethos 
With generous support from Macmillan Cancer Support, 
London Cancer is continuing its work to introduce the 
‘recovery package’ for all patients. This package combines 
several interventions which, when delivered together, aim 
to improve care co-ordination and outcomes for 
individuals living with or after a cancer diagnosis. The 
recovery package consists of: holistic needs assessment, 
treatment summaries, cancer care reviews (conducted by 
GPs) and health and wellbeing events. Since the beginning 
of the project, nine trusts have introduced holistic needs 
assessments, five have implemented treatment summaries 
and six host health and wellbeing events. We have agreed a 
standardised treatment summary template, which informs 
the patient and the GP of the care and treatment received, 
for embedding in all pathways. This document includes 
possible treatment toxicities and /or late effects; 
symptoms that require referral back to a specialist team, an 
ongoing management plan, and any required GP actions to 




While London Cancer has not yet achieved patient reported 
experience measures (PREMs) on all pathway scorecards, 
the work to galvanise the local health economy around the 
things that matter most is seeing all partner sites focus 
tremendous effort on improvement. The emphasis on 
what matters most to patients in London Cancer also 
requires patients and their carers to be active participants 
in all of our work. To date, 65 patients are actively 
involved in our day-to-day work. In addition to 
participation in pathway discussions, patients have 
provided invaluable feedback and input into improving 
information provision and the quality of clinical letters, 
designing patient measures for scorecards, creating content 
for the London Cancer website, co-designing improvement 
initiatives with clinicians and staff, leading and designing 
innovative research, and assisting commissioners in 
significant service redesign. It is clear from our work, 
however, and the continued focus on this over four years, 
that significant time is required for a truly patient centred 




Patient centred care that really shifts outcomes not just on 
paper but in the perception of the people we serve 
requires us to understand what matters most to patients. 
We have worked from this base and with this focus to 
direct and prioritise improvement efforts that meet the 
needs of patients and their clinicians.  In this article we 
have described an innovative patient-led and co-designed 
approach to service delivery, leadership and redesign, 
sustained through a new way of measuring for 
improvement. Our efforts to do this have been 
underpinned by the belief that if you start with the patient 
you have the best chance of keeping your work relevant, 
and making the biggest difference for your investment. 
Institutional alignment and traditional process 
measurement can have limited impact for change when 
patients actually experience care along entire pathways in 
multiple settings, each as individuals. Accepting this and 
looking to organise its work according to these principles, 
London Cancer’s partnership continues to be focused on 
change created by combining patient voice with clinical 
leadership, underpinned by data for improvement. We 
have outlined the ten things we keep central to our vision 
and how this is enabling the partners within London Cancer 
to achieve significant redesign of health care that had not 
been possible before in this geography. It is the work of 
these committed clinicians, health care leaders, charities 
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